Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0150504005
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02467518 | APOTEX INC | APO-CEFEPIME | Human | Yes | Prescription | 1 | CEFEPIME (CEFEPIME HYDROCHLORIDE) | 2 G / VIAL |
Dormant | 02319039 | APOTEX INC | CEFEPIME FOR INJECTION | Human | Yes | Prescription | 1 | CEFEPIME (CEFEPIME HYDROCHLORIDE) | 2 G / VIAL |
Marketed | 02499096 | HIKMA CANADA LIMITED | CEFEPIME FOR INJECTION USP | Human | Yes | Prescription | 1 | CEFEPIME (CEFEPIME HYDROCHLORIDE) | 2 G / VIAL |
Approved | 02464004 | QILU PHARMACEUTICAL CO., LTD. | CEFEPIME FOR INJECTION, USP | Human | Yes | Prescription | 1 | CEFEPIME (CEFEPIME HYDROCHLORIDE) | 2 G / VIAL |
Cancelled Post Market | 02163640 | BRISTOL-MYERS SQUIBB CANADA | MAXIPIME FOR INJECTION-PWS IV 2GM | Human | Yes | Prescription | 1 | CEFEPIME (CEFEPIME HYDROCHLORIDE) | 2 G / VIAL |
Application information
Related information
Contact us
Version 4.0.2